![]() |
市场调查报告书
商品编码
2008834
医疗机器人系统市场报告:按产品、部署类型、最终用户和地区划分(2026-2034 年)Medical Robotic Systems Market Report by Product, Deployment Mode, End User, and Region 2026-2034 |
||||||
2025年,全球医疗机器人系统市场规模达263亿美元。展望未来,IMARC集团预测,到2034年,该市场规模将达到978亿美元,2026年至2034年的复合年增长率为15.23%。技术创新、对微创手术需求的成长、慢性病盛行率的上升以及医疗领域的投资是推动市场成长的主要因素。
对微创手术的需求日益增长
微创手术中机器人系统的日益普及正在推动市场成长。由于併发症风险较低且住院时间较短,患者往往更倾向于选择微创手术。例如,浙江省荣军医院于2022年1月至2023年6月进行的一项横断面研究,纳入了305例静脉曲张(VV)患者,评估了患者的治疗方法偏好趋势。在96例做出治疗方法选择的患者中,约24.0%选择了传统手术,而76.0%选择了微创手术(MIT)。此外,製造商正在拓展产品线并升级现有系统,以满足对先进手术能力和技术创新的需求。例如,马尼帕尔医院(卡拉迪)于2024年4月推出了一项先进的机器人辅助膝关节关节重建手术,与传统手术相比,该手术具有更高的精度、更快的恢復速度和更少的不适感。其优点包括植入手术可达亚毫米级精度、降低感染风险以及24小时内即可早期康復出院。这项突破性技术使患者能够接受微创手术,缩短恢復时间,提高手术精确度,并提升生活品质。这些因素进一步推动了医疗机器人系统市场的成长。
手术机器人的引入
与传统手术技术相比,手术机器人具有更高的精准度、技巧和准确性,使外科医生能够完成复杂的手术。例如,梅奥诊所发表的报导指出,机器人技术能够帮助外科医生在手术过程中更精准、灵活、可靠地进行操作。与传统手术技术相比,机器人技术还能提高手术部位的可视性。透过机器人手术,外科医生可以完成其他技术难以甚至无法完成的复杂精细的治疗。此外,有利于机器人辅助手术的监管核准和保险报销政策也促进了市场成长。医疗监管机构认可机器人系统的临床优势,并透过简化核准流程来推动其应用。例如,2024年3月,Intuitive公司的第五代多埠机器人系统da Vinci 5获得了食品药物管理局 510(k)认证。该系统融合了150多项改进,拥有首个力回馈技术、新一代3D显示和影像处理技术,以及更高的精准度。重新设计的达文西5系统主机,能够自订姿势并在操作主机中更改设置,为外科医生提供了更大的舒适度。这些因素正在进一步加速全球医疗机器人系统市场的成长。
技术进步
现代医疗机器人系统利用高解析度摄影机、3D视觉化和即时影像处理等先进影像技术。这些技术使外科医生能够查看手术部位的详细放大影像,并精确地操作组织和器官。例如,2024年6月,医疗技术公司Endiatx推出了一款名为「PillBot」的机器人胶囊。这款可口服的机器人胶囊配备了摄影机、感测器和无线通讯功能,使临床医生能够以前所未有的精度和控制力检查消化道。这种更高的精确度降低了人为误差的风险,并改善了手术效果,尤其是在复杂的手术中。此外,人工智慧和机器学习演算法正越来越多地被整合到医疗机器人系统中,以增强决策能力并实现复杂任务的自动化。人工智慧系统能够即时分析大量数据,预测手术结果,并帮助外科医生更有效地规划和执行手术。例如,2023年10月,Body Vision Medical发布了其导航和即时成像平台「LungVision™」的新软体更新。此次更新包括最新的AI断层扫描成像演算法、简化的机器人辅助支气管镜检查(RAB)工作流程,以及降低肺结节切片检查过程中医务人员和患者的辐射暴露。这些因素将进一步扩大医疗机器人系统市场的规模。
The global medical robotic systems market size reached USD 26.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 97.8 Billion by 2034, exhibiting a growth rate (CAGR) of 15.23% during 2026-2034. Technological innovations, the rising demand for minimally invasive surgeries, the surging prevalence of chronic diseases, and investment in healthcare are primarily driving the market growth.
Increasing Demand for Minimally Invasive Surgeries
The increasing adoption of robotic systems for minimally invasive surgeries drives the market growth. Patients prefer minimally invasive surgery due to the lower risk of complications and reduced hospitalization periods. For instance, according to a cross-sectional study of 305 VV-afflicted patients at Zhejiang Rongjun Hospital between January 2022 and June 2023 evaluated the treatment preferences of the patients. Out of the 96 patients who selected an option of treatment, nearly 24.0% went with traditional surgery, and 76.0% went with MIT. Moreover, manufacturers are expanding their product offerings and upgrading existing systems to meet the demand for advanced surgical capabilities and technological innovations. For instance, in April 2024, Manipal Hospital, Kharadi, launched advanced robotic knee replacement surgery, which promised more precision, faster recovery times, and less discomfort than traditional surgeries. This provides advantages, such as sub-millimeter accuracy during implant surgery, a lower risk of infection, and the prospect of speedier recovery and release within 24 hours. This breakthrough technique allows patients to have minimally invasive surgery with reduced recovery periods, higher precision, and a better quality of life. These factors are further driving the medical robotic systems market growth.
Adoption of Surgical Robots
Surgical robots offer superior precision, skill, and accuracy compared to traditional surgical techniques. They enable surgeons to perform complex procedures. For instance, according to an article published by Mayo Clinic, during surgery, robotic technology can help surgeons be more precise, flexible, and in control. When compared to conventional surgical techniques, robotic technology also improves the visibility of the operating site. Surgeons can carry out intricate and delicate treatments with robotic surgery that would be challenging or impossible to accomplish with other techniques. Besides this, favorable regulatory approvals and reimbursement policies for robotic-assisted surgeries support market growth. Healthcare regulatory bodies recognize the clinical benefits of robotic systems and encourage their adoption through streamlined approval processes. For example, in March 2024, Intuitive received U.S. Food and Drug Administration (FDA) 510(k) certification for their fifth-generation multiport robotic system, called da Vinci 5. With more than 150 improvements, it boasts the first force-sensing technology, a next-generation 3D display and image processing, and increased precision. With customizable posture and the option to make changes while using the console, the da Vinci 5 system's revamped console provides surgeons with increased comfort. These factors are further escalating the growth of the global medical robotic systems market.
Technological Advancements
Modern medical robotic systems leverage advanced imaging technologies, such as high-definition cameras, 3D visualization, and real-time image processing. These technologies provide surgeons with detailed, magnified views of the surgical site, enabling precise manipulation of tissues and organs. For instance, in June 2024, Endiatx, a medical technology company, unveiled its robotic pill to the market. The PillBot is an ingestible robotic capsule that has cameras, sensors, and wireless communication capabilities, allowing clinicians to investigate the gastrointestinal tract with unprecedented accuracy and control. Enhanced accuracy reduces the risk of human error and improves surgical outcomes, particularly in complex procedures. Besides this, AI and machine learning algorithms are increasingly integrated into medical robotic systems to enhance decision-making capabilities and automate complex tasks. AI-powered systems can analyze vast amounts of data in real-time, predict surgical outcomes, and assist surgeons in planning and executing procedures more effectively. For example, in October 2023, Body Vision Medical launched a new software update for its LungVision(TM) navigation and real-time imaging platform. The update includes the latest AI Tomography imaging algorithm, a streamlined workflow for robotic-assisted bronchoscopy (RAB), reduced radiation exposure for medical staff and patients during lung nodule biopsy procedures, etc. These factors are further driving the medical robotic systems market size.
Surgical robots represented the largest segment
According to the medical robotic systems market overview, surgical robots enable minimally invasive procedures with smaller incisions, reduced trauma to surrounding tissues, and faster recovery times compared to traditional open surgeries. Patients benefit from less pain, shorter hospital stays, and quicker return to normal activities, driving demand for robotic-assisted surgeries. They offer enhanced precision and accuracy in surgical maneuvers, leveraging advanced imaging, robotic arm talent, and real-time feedback mechanisms. Surgeons can perform complex procedures with greater control and precision, minimizing risks and improving surgical outcomes. For instance, in June 2024, SS Innovations, the developer of India's first indigenous surgical robotic system, launched SSI Mantra 3, a robotic system that enables affordable access to the next generation of surgical innovation.
On-premises medical robotic systems are hosted and managed within the healthcare facility's infrastructure, typically within a dedicated surgical suite or operating room. Moreover, healthcare providers have full control over the system's hardware, software, and data management, which is positively influencing the medical robotic systems market prediction. This allows for stringent security measures and compliance with healthcare data privacy regulations. At the same time, cloud-based medical robotic systems leverage cloud computing infrastructure to store data and perform computational tasks remotely. This enables access to robotic capabilities from multiple locations, including different healthcare facilities and remote surgical centers.
Hospitals are major users of medical robotic systems, particularly for complex surgeries that require precision and advanced capabilities. Robotic systems enable surgeons to perform intricate procedures with enhanced precision, reducing the risk of complications and improving patient outcomes. While ASCs increasingly adopt medical robotic systems for performing minimally invasive surgeries (MIS), such as laparoscopic procedures, hernia repairs, and outpatient orthopedic surgeries. Robotic-assisted techniques allow ASCs to offer advanced surgical options with quicker recovery times and reduced post-operative pain. Besides this, in rehabilitation centers, medical robotics are used for neurorehabilitation therapies and assistive technologies. Robotic exoskeletons, prosthetics, and rehabilitation robots help patients regain mobility, improve muscle strength, and facilitate recovery from neurological conditions and musculoskeletal injuries.
North America accounts for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
According to the medical robotic systems market statistics, continuous innovation in robotic technology, including AI integration, advanced imaging capabilities, and enhanced surgical navigation systems, has expanded the applications and precision of medical robotic systems in the region. These advancements improve surgical outcomes and patient safety, driving adoption across various specialties. Moreover, there is an increasing preference for minimally invasive procedures due to reduced recovery times, shorter hospital stays, and improved patient outcomes. Medical robotic systems enable surgeons to perform complex surgeries through smaller incisions with greater precision, enhancing the appeal of robotic-assisted procedures. For instance, in September 2023, U.S. Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) launched the new Canady Robotic AI Surgical System.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: